Skip to main content

Table 7 Effect of Curcuma longa extract (CLE) on the Profile of Mood States (POMS) scoresa

From: Curcuma longa extract improves serum inflammatory markers and mental health in healthy participants who are overweight: a randomized, double-blind, placebo-controlled trial

  Change from baseline Repeated measures two-way ANOVA
  Week 4 Week 8 Week 12 Group Time Interaction
  Mean SD Mean SD Mean SD
Anger-hostility (AH)
 Placebo 1.95 4.76 1.55 6.02 1.75 5.29 0.022 0.706 0.472
 CLE −0.69* 5.37 0.16 6.01 −1.10* 5.40
Confusion-bewilderment (CB)
 Placebo −0.10 4.80 0.82 6.16 0.00 4.54 0.885 0.956 0.367
 CLE −0.64 4.37 0.71 5.93 −0.97 4.49
Depression-dejection (DD)
 Placebo 0.90 4.42 0.53 4.86 0.35 5.37 0.312 0.287 0.285
 CLE −0.64 4.37 0.71 5.93 −0.97 4.49
Fatigue-inertia (FI)
 Placebo −0.03 4.81 −0.70 4.87 −0.25 5.23
6.82
0.900 0.433 0.294
 CLE −0.05 6.73 0.11 7.05 −1.46
Tension-anxiety (TA)
 Placebo −1.70 7.77 −2.58 6.00 −1.48 6.99 0.331 0.469 0.108
 CLE 0.10 7.36 −0.18 7.00 −1.90 6.69
Vigor-activity (VA)
 Placebo 1.58 7.19 1.08 8.23 2.10 8.74 0.141 0.184 0.841
 CLE −0.23 5.94 −1.55 6.20 0.13 7.81
Friendliness (F)
 Placebo 0.05 8.19 −0.63 9.62 − 0.33 8.46 0.983 0.706 0.989
 CLE 0.00 7.19 −0.45 7.83 −0.15 8.79
Total mood disturbance (TMD)
 Placebo −0.05 4.62 −0.65 4.15 −0.28 3.89 0.894 0.374 0.109
 CLE −0.23 5.04 0.68 6.54 −1.08 5.48
  1. aValues represent the means and standard deviations for n = 40 (placebo group) or n = 39 (CLE group). *p < 0.05: Significant difference from the placebo group by repeated measures two-way ANOVA, followed by the two-tailed unpaired Student’s t test when variance was homogeneous or the Aspin-Welch t test when variance was heterogeneous